Integra LifeSciences Holdings (IART) — Capital Reinvestment Ratio
Integra LifeSciences Holdings (IART) has a Capital Reinvestment Ratio of 1.51x as of March 2026, meaning it reinvests 2% of its operating cash flow ($9.80 Million) in capital expenditures ($14.85 Million). Check Integra LifeSciences Holdings tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Integra LifeSciences Holdings Capital Reinvestment Ratio (1999–2025)
This chart tracks Integra LifeSciences Holdings's Capital Reinvestment Ratio across 26 annual periods. For the full cash flow conversion analysis, see IART cash flow conversion.
Annual Capital Reinvestment Ratio for Integra LifeSciences Holdings (1999–2025)
Year-by-year Capital Reinvestment Ratio for Integra LifeSciences Holdings from 1999 to 2025. See Integra LifeSciences Holdings free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.62x | $50.38 Million | $81.44 Million | ▲ +100.3% |
| 2024 | 0.81x | $129.38 Million | $104.42 Million | ▲ +68.9% |
| 2023 | 0.48x | $139.96 Million | $66.86 Million | ▲ +168.4% |
| 2022 | 0.18x | $264.47 Million | $47.09 Million | ▲ +15.7% |
| 2021 | 0.15x | $312.43 Million | $48.08 Million | ▼ -50.9% |
| 2020 | 0.31x | $203.83 Million | $63.89 Million | ▼ -46.1% |
| 2019 | 0.58x | $231.43 Million | $134.53 Million | ▲ +49.3% |
| 2018 | 0.39x | $199.68 Million | $77.74 Million | ▲ +2.5% |
| 2017 | 0.38x | $114.54 Million | $43.50 Million | ▼ -6.6% |
| 2016 | 0.41x | $116.41 Million | $47.33 Million | ▲ +15.0% |
| 2015 | 0.35x | $94.48 Million | $33.41 Million | ▼ -33.7% |
| 2014 | 0.53x | $79.46 Million | $42.40 Million | ▼ -40.6% |
| 2013 | 0.90x | $53.27 Million | $47.85 Million | ▼ -23.6% |
| 2012 | 1.18x | $58.72 Million | $69.03 Million | ▲ +219.2% |
| 2011 | 0.37x | $104.33 Million | $38.42 Million | ▲ +4.7% |
| 2010 | 0.35x | $105.57 Million | $37.14 Million | ▲ +82.8% |
| 2009 | 0.19x | $143.24 Million | $27.57 Million | ▲ +4.3% |
| 2008 | 0.18x | $72.59 Million | $13.40 Million | ▼ -61.5% |
| 2007 | 0.48x | $47.03 Million | $22.57 Million | ▲ +198.8% |
| 2006 | 0.16x | $71.70 Million | $11.52 Million | ▲ +13.4% |
| 2005 | 0.14x | $56.85 Million | $8.05 Million | ▼ -35.1% |
| 2004 | 0.22x | $38.98 Million | $8.51 Million | ▲ +97.8% |
| 2003 | 0.11x | $34.83 Million | $3.84 Million | ▲ +56.6% |
| 2002 | 0.07x | $31.98 Million | $2.25 Million | ▼ -61.3% |
| 2001 | 0.18x | $15.70 Million | $2.86 Million | ▼ -97.4% |
| 1999 | 6.92x | $2.50 Million | $17.30 Million | — |